Lv3
268 积分 2023-05-25 加入
Global Burden of the Key Components of Cardiovascular-Kidney-Metabolic Syndrome
16天前
已完结
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
16天前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
22天前
已完结
Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors
1个月前
已完结
Discovery of Darovasertib (NVP-LXS196), a Pan-PKC Inhibitor for the Treatment of Metastatic Uveal Melanoma
2个月前
已完结
Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now
2个月前
已完结
Uveal Melanoma Treatment: An Update
2个月前
已完结
Treatment Patterns and Real-World Outcomes of Molecular Subgroups in Patients With AML Receiving Frontline Venetoclax-Based Therapy
3个月前
已关闭
Mechanisms of Clinical Resistance to Selective FGFR2 Inhibition by Lirafugratinib
3个月前
已关闭
Isocitrate Dehydrogenase Mutations in Cancer: Mechanisms of Transformation and Metabolic Liability
3个月前
已完结
皖公网安备34019202002308
